Oct 2026· Frontiers in Cell and Developmental Biology· Vol 14· 0 citations· 35 references
TL;DR
These findings prioritize an immunometabolic framework linking gut microbial variation to cardiac arrest risk, with metabolic mediation representing the predominant candidate layer for follow-up study.
Abstract
Cardiac arrest remains difficult to predict, and upstream biological determinants are poorly defined. Gut microbiota can influence host metabolism, immunity and inflammation, but their relevance to cardiac arrest risk remains unclear.
We performed bidirectional two-sample Mendelian randomization to prioritize associations between gut microbial traits and cardiac arrest. Two-step mediation analyses were then used to assess whether circulating metabolites, immune cell phenotypes and inflammatory proteins could represent candidate intermediary pathways. An independent exploratory fecal 16S rRNA cohort of patients with cardiac arrest and healthy controls was analysed to provide descriptive post-arrest microbiome context.
Mendelian randomization prioritized 14 candidate gut microbial taxa or microbial metabolic pathways associated with cardiac arrest risk. Mediation analyses identified 55 candidate mediation pathways involving 41 candidate mediators, including 10 pathways with comparatively stronger statistical support based on the joint-significance criterion and the Sobel test. Metabolite-related signals accounted for most candidate mediation pathways, with additional contributions from immune cell phenotypes and inflammatory factors. In the exploratory 16S cohort, diversity and ordination patterns did not show robust group separation, whereas descriptive compositional summaries showed partial taxonomic overlap with signals highlighted by the genetic analyses; these observations were not considered directional or causal validation.
These findings prioritize an immunometabolic framework linking gut microbial variation to cardiac arrest risk, with metabolic mediation representing the predominant candidate layer for follow-up study. The exploratory clinical 16S results provide descriptive post-arrest context rather than independent validation, and the genetic findings should be interpreted as candidate associations requiring larger prospective and experimental confirmation.
Gut microbial dysbiosis is an essential factor dependent on immune regulation; however, complex interactions among microbial communities, metabolites and immune responses remain inefficiently characterized. This research develops an integrative multi-omics analysis of gut microbial dysbiosis associated with immune dysf...
Bao Luong, Chi· International Journal of Dru...· 0 citations
This study provides genetic evidence supporting potential roles of inflammatory proteins and metabolites in SSTI susceptibility and highlights a counteracting metabolic pathway related to IL-10.
Jie-Wang-Xian-Zhong-Wu-Yan-Xia-Chen-Xin-Chen-Chen- Tang, Yi Chen, Yue-Ru Ji et al.· Clinical, Cosmetic and Inves...· 0 citations
BACKGROUND
The gut microbiota is increasingly recognized as a modulator of metabolic health in children, influencing nutrient absorption, immune tone, epithelial barrier function, and energy homeostasis. This review summarizes current evidence on microbial signatures and mechanistic pathways associated with pediatric o...
Shan-Shan Xie, Jie Hu, Wei Zhou et al.· World Journal of Pediatrics· 0 citations
The corrected Bifidobacterium-related UTI association was the principal MR finding, while the broader analysis identified exploratory microbiota–infection patterns.
Feng-Ning Chen, Chi Zhang, Guang-Yue Yao et al.· Frontiers in Microbiology· 0 citations
A multi-step Mendelian randomization framework was adopted to investigate the causal effects of gut microbiota on EL and the mediating role of blood metabolites, and pathway analysis was conducted to verify the biological plausibility of the enriched metabolic pathways.
Z. Chen, T. Jiang, Y. Yang et al.· medRxiv· 0 citations
Background/Objectives: Colorectal neoplasia is accompanied by reproducible changes in the gut microbiome and fecal metabolome, but the receptor systems through which altered microbial metabolic outputs may interface with the host remain incompletely defined. We investigated whether disease-associated microbial function...
M. Spathakis, G. Kolios, V. Paspaliaris et al.· Pharmaceuticals· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.